Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

PowerVR AX3125 is a cost-sensitive solution for low-power applications – i.e. where power draw is a key issue. It can run at up to 0.6 TOPS in IoT devices, entry-level smart cameras, embedded ... The ...

Investors with a lot of money to spend have taken a bullish stance on DexCom DXCM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the positions showed up on publicly available ...

DexCom has a significant (and expanding) growth runway in its market. Vertex Pharmaceuticals is an innovative biotech with a growing lineup and rich pipeline. Both stocks should deliver excellent ...

DexCom has done a decent job managing its cost base over the last five years. The company has produced an average operating margin of 14.4%, higher than the broader healthcare sector. Looking at ...

DexCom's growth is slowing ... company is addressing the issue with the DME sales channel, this has already cost the company a dent on the growth front. While this was management’s justification ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

Shares of DexCom Inc. DXCM slipped 2.69% to $85.99 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.76% to 5,849.72 and ...